Tables
TABLE 1 FUNDING SCENARIO 17
TABLE 2 GLOBAL CANCER DIAGNOSTICS MARKET REVENUE BY REGIONS' 2017-2024 ($MILLION) 44
TABLE 3 OTHER PROMINENT VENDORS OF CANCER DIAGNOSTICS MARKET 54
TABLE 4 F. HOFFMANN-LA ROCHE: OFFERINGS 56
TABLE 5 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 57
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 63
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 66
TABLE 8 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 72
TABLE 9 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 74
TABLE 10 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 81
TABLE 11 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS 82
TABLE 12 GE HEALTHCARE: PRODUCT OFFERINGS 89
TABLE 13 GE HEALTHCARE: RECENT DEVELOPMENTS 90
TABLE 14 QIAGEN N.V.: SNAPSHOT 97
TABLE 15 QIAGEN N.V.: RECENT DEVELOPMENTS 97
TABLE 16 BIOMERIEUX S.A.: SNAPSHOT 100
TABLE 17 AGILENT TECHNOLOGIES: SNAPSHOT 102
TABLE 18 BECTON DICKINSON AND COMPANY: SNAPSHOT 105
TABLE 19 HOLOGIC INC.: SNAPSHOT 106
TABLE 20 ILLUMINA INC: SNAPSHOT 109
TABLE 21 KONINKLIJKE PHILIPS N.V.: SNAPSHOT 113
?
LIST OF FIGURE
Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL CANCER DIAGNOSTICS MARKET 12
CHART 2 GLOBAL CANCER DIAGNOSTICS MARKET REVENUE' 2017-2024 ($MILLION) 15
CHART 3 SEGMENTATION OF GLOBAL CANCER DIAGNOSTICS MARKET 19
CHART 4 PEST ANALYSIS OF GLOBAL CANCER DIAGNOSTICS MARKET 19
CHART 5 PORTER 5 FORCES ON GLOBAL CANCER DIAGNOSTICS MARKET 20
CHART 6 DRO - IMPACT ANALYSIS OF GLOBAL CANCER DIAGNOSTICS MARKET 26
CHART 7 KEY STAKEHOLDERS 26
CHART 8 GLOBAL CANCER DIAGNOSTICS MARKET BY METHOD OF DIAGNOSIS SEGMENTATION' 2017 (%) 28
CHART 9 GLOBAL CANCER DIAGNOSTICS MARKET BY METHOD OF DIAGNOSIS SEGMENTATION' 2017 (%) 28
CHART 10 GLOBAL TUMOUR BIOMARKER TESTSING MARKET FORECAST' 2017-2024 ($MILLION) 30
CHART 11 GLOBAL TISSUE DIAGNOSTICS MARKET FORECAST' 2017-2024 ($MILLION) 32
CHART 12 GLOBAL LIQUID BIOPSY MARKET FORECAST' 2017-2024 ($MILLION) 33
CHART 13 GLOBAL IMAGING MARKET FORECAST' 2017-2024 ($MILLION) 33
CHART 14 GLOBAL IMAGING MARKET BY TYPE SEGMENTATION' 2017 (%) 34
CHART 15 GLOBAL OTHERS MARKET FORECAST' 2017-2024 ($MILLION) 37
CHART 16 GLOBAL CANCER DIAGNOSTICS MARKET BY APPLICATION SEGMENTATION' 2017 (%) 38
CHART 17 GLOBAL CANCER DIAGNOSTICS MARKET BY END-USERS SEGMENTATION' 2017 (%) 41
CHART 18 GLOBAL CANCER DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION' 2017 (%) 44
CHART 19 CANCER DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($MILLION) 45
CHART 20 CANCER DIAGNOSTICS MARKET REVENUE IN EUROPE' 2017-2024 ($MILLION) 46
CHART 21 CANCER DIAGNOSTICS REVENUE IN ASIA-PACIFIC' 2017-2024 ($MILLION) 48
CHART 22 CANCER DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($MILLION) 51
CHART 27 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 68
CHART 28 ABBOTT LABORATORIES.: BUSINESS UNITS 69
CHART 29 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 69
CHART 30 ABBOTT LABORATORIES.: SWOT ANALYSIS 71
CHART 31 SIEMENS AG: OVERVIEW SNAPSHOT 76
CHART 32 SIEMENS AG: BUSINESS UNITS 77
CHART 33 SIEMENS AG: GEOGRAPHIC PRESENCE 79
CHART 34 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 80
CHART 35 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 84
CHART 36 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE 85
CHART 37 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE 87
CHART 38 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 88
CHART 39 GE HEALTHCARE: OVERVIEW SNAPSHOT 92
CHART 40 GE HELATHCARE: BUSINES UNITS 94
CHART 41 GE HEALTHACRE: GEOGRAPHY 95
CHART 42 GE HEALTHCARE: SWOT ANALYSIS 95